Prodrugs of 2-(3,5-Dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone
US-2024083925-A1 · Mar 14, 2024 · US
Ates Ali is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ates Ali |
| Total patents | 11 |
| First publication | Jan 8, 2015 |
| Latest publication | Mar 14, 2024 |
Publications ranked by popularity score, then publication date.
US-2024083925-A1 · Mar 14, 2024 · US
US-2024043400-A1 · Feb 8, 2024 · US
US-2022259179-A1 · Aug 18, 2022 · US
US-10370355-B2 · Aug 6, 2019 · US
US-2019106406-A1 · Apr 11, 2019 · US
US-10105359-B2 · Oct 23, 2018 · US
US-9975873-B2 · May 22, 2018 · US
US-2017313677-A1 · Nov 2, 2017 · US
US-2017304292-A1 · Oct 26, 2017 · US
US-9067930-B2 · Jun 30, 2015 · US
Latest publications not already listed above.
US-2015011526-A1 · Jan 8, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ucb Biopharma Sprl | 6 |
| UCB Biopharma SRL | 3 |
| Ucb Pharma Sa | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/06 | 9 |
| A61P25/16 | 8 |
| A61P25/28 | 6 |
| A61P25/30 | 5 |
| A61P25/20 | 5 |